权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Role of miR96 in Pulmonary Arterial Hypertension

miR96 在肺动脉高压中的作用

基本信息

批准号：
MR/N011112/1
负责人：
Margaret MacLean
金额：
$ 75.85万
依托单位：
University of Glasgow
依托单位国家：
英国
项目类别：
Research Grant
财政年份：
2016
资助国家：
英国
起止时间：
2016 至无数据
项目状态：
已结题

来源：
https://gtr.ukri.org/projects?ref=MR%2FN011112%2F1
关键词：
Role miR96 Pulmonary Arterial Hypertension

项目摘要

Pulmonary arterial hypertension (PAH) is a devasting disease with a very poor survival rate. It occurs more frequently in women and involves the closing down of lung arteries due to thickening of their walls (remodelling). This puts a strain on the heart and causes failure of the right ventricle of the heart and death. Serotonin is a chemical that can cause this remodelling and it acts via a protein called a 5HT1B receptor. Small pieces of RNA called microRNAs can regulate genes and microRNA96 can decrease the number of 5HT1B receptors thus reducing the disease-causing effects of serotonin. In lung cells from female PAH patients or animal models, there can be a deficiency in this microRNA96 which causes an increase in the number of 5HT1B receptors. We have shown that restoring the levels of microRNA96 in lung arteries using a microRNA96 'mimic' by injection can decrease the number of 5HT1B receptors and can reverse pulmonary hypertension in mouse and rat models of the disease. Here we wish to understand fully how this mimic works. We will also determine the best way to administer the mimic, the best dose, if it has side effects and if it would work better with other drugs.

肺动脉高压（PAH）是一种生存率极低的毁灭性疾病。它在女性中更常见，并且涉及由于肺动脉壁增厚而导致的肺动脉关闭（重塑）。这会对心脏造成压力，导致心脏右心室衰竭和死亡。血清素是一种化学物质，可以引起这种重塑，它通过一种称为5 HT 1B受体的蛋白质起作用。称为microRNA的小片段RNA可以调节基因，microRNA 96可以减少5 HT 1B受体的数量，从而减少5-羟色胺的致病作用。在女性PAH患者或动物模型的肺细胞中，这种microRNA 96可能存在缺陷，导致5 HT 1B受体数量增加。我们已经证明，通过注射microRNA 96“模拟物”恢复肺动脉中microRNA 96的水平可以减少5 HT 1B受体的数量，并可以逆转小鼠和大鼠模型中的肺动脉高压。在这里，我们希望充分了解这种模仿是如何工作的。我们还将确定最佳的方式来管理模拟，最佳剂量，如果它有副作用，如果它会更好地与其他药物。

项目成果

期刊论文数量（5）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Direct Delivery of MicroRNA96 to the Lungs Reduces Progression of Sugen/Hypoxia-Induced Pulmonary Hypertension in the Rat.

DOI：
10.1016/j.omtn.2020.09.002
发表时间：
2020-12-04
期刊：
Molecular therapy. Nucleic acids
影响因子：
0
作者：
Docherty CK;Denver N;Fisher S;Nilsen M;Hillyard D;Openshaw RL;Labazi H;MacLean MR
通讯作者：
MacLean MR

A Microrna96 Mimic Delivered Direct To The Lungs Can Reverse Sugen/hypoxia-induced Pulmonary Hypertension In The Rat

直接输送到肺部的 Microrna96 模拟物可以逆转大鼠体内 Sugen/缺氧引起的肺动脉高压